TNF Inhibitors: When Traditional RA-Fighters Arent Enough

New drugs to manage rheumatoid arthritis have become easier to use-and there are more promising developments in the pipeline.

Slowing joint destruction is the goal of nearly all rheumatoid arthritis (RA) drugs. And doctors are getting more aggressive about using these drugs earlier in the disease process in order to halt such changes before they become permanent or irreversible.
To continue reading this article or issue you must be a paid subscriber. Sign in

Subscribe to Arthritis Advisor

Get the next year of Arthritis Advisor for just $20. And access all of our online content - over 1,000 articles - free of charge.
Subscribe today and save 36%. It's like getting 4 months FREE!
Already Subscribed?
Click Here to Sign In | Forgot your password? | Activate Web Access